Systems-based pharmacogenomics reveals that the ubiquitin ligase SCF-SKP2 is a molecular determinant of clinical response to bortezomib-based therapy
Research Abstract
NULL
Research Department
Research Journal
ACR Annual Meeting 2015, Philadelphia, Pennsylvania, USA
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
3
Research Vol
NULL
Research Website
NULL
Research Year
2015
Do you have any questions?